AGENUS INC Logo

AGENUS INC

A clinical-stage biotechnology company specializing in immuno-oncology therapies.

AGEN | US

Overview

Corporate Details

ISIN(s):
US00847G8042
LEI:
Country:
United States of America
Address:
3 FORBES ROAD, 2421 LEXINGTON

Description

Agenus Inc. is a clinical-stage biotechnology company specializing in immuno-oncology (I-O). The company discovers, develops, and manufactures therapies designed to activate the body's immune system to combat cancer and infectious diseases. Its portfolio includes a broad range of immunological agents such as antibody therapeutics, adoptive cell therapies, and vaccine adjuvants. A key program is botensilimab, a next-generation CTLA-4 antibody engineered for enhanced efficacy and improved tolerability. Agenus aims to expand the patient population benefiting from I-O, including those with tumors unresponsive to current treatments, by leveraging innovative combination approaches and strategic partnerships.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-12-15 17:05
4
English ZIP 7.7 KB
2025-12-01 17:05
4
English ZIP 7.7 KB
2025-11-17 17:05
4
English ZIP 7.7 KB
2025-11-10 18:12
10-Q
English ZIP 2.0 MB
2025-11-10 08:32
8-K
English ZIP 284.3 KB
2025-11-05 17:05
4
English ZIP 7.7 KB
2025-10-30 15:24 English ZIP 8.1 KB
2025-10-21 18:05
4
English ZIP 7.7 KB
2025-10-09 18:05
8-K
English ZIP 52.2 KB
2025-10-06 18:05
4
English ZIP 7.7 KB
2025-10-03 18:05
4
English ZIP 6.8 KB
2025-10-03 18:05
4
English ZIP 7.3 KB
2025-09-23 19:12
8-K
English ZIP 49.6 KB
2025-09-23 18:05
4
English ZIP 7.7 KB
2025-09-09 18:05
4
English ZIP 7.7 KB

Automate Your Workflow. Get a real-time feed of all AGENUS INC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for AGENUS INC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for AGENUS INC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Develops drugs for intractable diseases by regulating oxidative stress and CAFs.
South Korea
293780
Aptamer Sciences Inc Logo
Clinical-stage company developing aptamer-based therapeutics for oncology.
South Korea
291650
Aptorum Group Ltd Logo
Clinical-stage biopharma developing therapeutics for oncology and infectious diseases.
United States of America
APM
Aquestive Therapeutics, Inc. Logo
Pharmaceutical company developing oral film medicines for CNS and allergic reactions.
United States of America
AQST
Arbutus Biopharma Corp Logo
Clinical-stage biopharma company developing a functional cure for chronic Hepatitis B.
United States of America
ABUS
Arcellx, Inc. Logo
A clinical-stage biotech company developing immunotherapies for cancer and autoimmune diseases.
United States of America
ACLX
Arctic Bioscience Logo
Develops pharmaceutical and nutraceutical products from marine membrane lipids.
Norway
ABS
ArcticZymes Technologies Logo
Develops and manufactures novel recombinant enzymes from Arctic marine organisms.
Norway
AZT
Arcturus Therapeutics Holdings Inc. Logo
A commercial-stage mRNA medicines company focused on rare and infectious diseases.
United States of America
ARCT
Arcus Biosciences, Inc. Logo
A clinical-stage biopharmaceutical company developing combination therapies for cancer.
United States of America
RCUS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.